Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.21T, Eli Lilly(LLY) trades at $1,269.78. The stock has a price-to-earnings ratio of 43.47 and currently yields dividends of 0.52%.
During the trading session on 2026-10-28, Eli Lilly(LLY) shares reached a daily high of $1,272.50 and a low of $1,268.00. At a current price of $1,269.78, the stock is +0.1% higher than the low and still -0.2% under the high.
Trading activity shows a volume of 10.15K, compared to an average daily volume of 2.5M.
The stock's 52-week range extends from a low of $809.63 to a high of $1,321.21.
The stock's 52-week range extends from a low of $809.63 to a high of $1,321.21.
LLY News
...
Eli Lilly and Company (NYSE:LLY) will release its third quarter earnings report before the opening bell on Thursday, Oct. 29. Analysts expect the Indianapolis,...
Chicago, IL – October 28, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the l...
Analyst ratings
85%
of 33 ratingsMore LLY News
Eli Lilly (LLY +0.22%) has achieved several impressive milestones over the past five years, including becoming the first healthcare company to reach a $1 trilli...
has delivered a powerful run over the past few years, and with the stock recently closing at US$1,279.14, the key issue for investors is how well that price lin...
Eli Lilly (NYSE:LLY) can continue running advertisements for its weight-loss medicines after a federal judge rejected Novo Nordisk A/S‘ (NYSE:NVO) request for a...
Expectations are running high for Eli Lilly’s (LLY) upcoming financial results on Oct. 29. Several analysts on Wall Street expect the latest print from the phar...
Eli Lilly (NYSE:LLY) reported Phase 1 data for sofetabart mipitecan (Sofe-M) plus bevacizumab in platinum-sensitive ovarian cancer. The investigational ADC com...
Bristol Myers Squibb's (BMY -2.41%) price-to-forward earnings ratio is around 9.7x, which is slightly above its five-year average. However, pharmaceutical compe...
Are you looking for a stable dividend payer or a high-growth medical innovator? Choosing between Amgen (AMGN +2.04%) and Eli Lilly & Co. (LLY +2.83%) depends on...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.